BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35198098)

  • 21. Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma.
    Pinto A; Signoretti S; Hirsch MS; Barletta JA
    Histopathology; 2015 May; 66(6):901-4. PubMed ID: 25130952
    [No Abstract]   [Full Text] [Related]  

  • 22. Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process.
    Lenci N; Francesco P; Scarciglia E; Fiorentino V; Schino M; Palermo G; Racioppi M; Bassi P; Martini M
    Med Mol Morphol; 2021 Jun; 54(2):187-191. PubMed ID: 33175195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
    Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
    [No Abstract]   [Full Text] [Related]  

  • 24. Multifocal metanephric adenoma in childhood.
    Kohashi K; Oda Y; Nakamori M; Yamamoto H; Tamiya S; Toubo T; Kinoshita Y; Tajiri T; Taguchi T; Tsuneyoshi M
    Pathol Int; 2009 Jan; 59(1):49-52. PubMed ID: 19121092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
    de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis].
    Wang X; Wu N; Yang WR; Shi SS; Ma HH; Wei X; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):457-61. PubMed ID: 27430690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
    Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction.
    Paja Fano M; Ugalde Olano A; Fuertes Thomas E; Oleaga Alday A
    Endocrinol Diabetes Nutr; 2017 Feb; 64(2):75-81. PubMed ID: 28440781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
    Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
    Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
    Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
    Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma].
    Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
    Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
    Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma.
    Hiromoto T; Murakami T; Akazawa Y; Sasahara N; Saito T; Sakamoto N; Mitomi H; Nagahara A; Yao T
    Histopathology; 2018 Sep; 73(3):444-453. PubMed ID: 29729192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes.
    Hsieh MS; Bishop JA; Wang YP; Poh CF; Cheng YL; Lee YH; Jin YT; Chang JYF
    Head Neck Pathol; 2020 Jun; 14(2):489-496. PubMed ID: 31473937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms.
    Bodnar M; Burduk P; Antosik P; Jarmuz-Szymczak M; Wierzbicka M; Marszalek A
    J Oral Pathol Med; 2017 May; 46(5):340-345. PubMed ID: 27682157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
    Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
    Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.